| Dr Adam Seth Schneiderman, M D | |
|
165 N Village Ave, Suite 132, Rockville Centre, NY 11570-3761 | |
| (516) 766-5851 | |
| (516) 766-5959 |
| Full Name | Dr Adam Seth Schneiderman |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 27 Years |
| Location | 165 N Village Ave, Rockville Centre, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1700823325 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 220182-1 (New York) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Union Square Eye Center Llc | 9133451438 | 10 |
News Archive
Elizabeth Warren and Senator Scott P. Brown kept the pressure on each other throughout a feisty, hourlong debate here Wednesday night. … Asked where he would cut the government, Mr. Brown cited President Obama's health care law, which, he said, was crushing Massachusetts businesses. He said the law would remove $700 billion from Medicare, an assertion that Mr. Romney made in last week's presidential debate.
Scientists from the University of Surrey have developed 'intelligent' nanoparticles which heat up to a temperature high enough to kill cancerous cells - but which then self-regulate and lose heat before they get hot enough to harm healthy tissue.
Dr. Reddy's Laboratories, announced today that the U.S. Food and Drug Administration has approved ZEMBRACESymTouch (sumatriptan succinate) injection, a drug-device combination product intended for the treatment of acute migraine episodes, with or without aura, in adults who are inadequately managed with existing treatment regimens.
Membrane proteins are the "gatekeepers" that allow information and molecules to pass into and out of a cell. Until recently, the microscopic study of these complex proteins has been restricted due to limitations of "force microscopes" that are available to researchers and the one-dimensional results these microscopes reveal.
A study published in the March 2013 issue of the Journal of the American Academy of Child and Adolescent Psychiatry found that 9 out of 10 young children with moderate to severe attention-deficit/hyperactivity disorder (ADHD) continue to experience serious to severe symptoms and impairment long after their original diagnoses, and in many cases, despite treatment.
› Verified 1 days ago
| Entity Name | Union Square Eye Care Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508188038 PECOS PAC ID: 2062548092 Enrollment ID: O20100330000309 |
News Archive
Elizabeth Warren and Senator Scott P. Brown kept the pressure on each other throughout a feisty, hourlong debate here Wednesday night. … Asked where he would cut the government, Mr. Brown cited President Obama's health care law, which, he said, was crushing Massachusetts businesses. He said the law would remove $700 billion from Medicare, an assertion that Mr. Romney made in last week's presidential debate.
Scientists from the University of Surrey have developed 'intelligent' nanoparticles which heat up to a temperature high enough to kill cancerous cells - but which then self-regulate and lose heat before they get hot enough to harm healthy tissue.
Dr. Reddy's Laboratories, announced today that the U.S. Food and Drug Administration has approved ZEMBRACESymTouch (sumatriptan succinate) injection, a drug-device combination product intended for the treatment of acute migraine episodes, with or without aura, in adults who are inadequately managed with existing treatment regimens.
Membrane proteins are the "gatekeepers" that allow information and molecules to pass into and out of a cell. Until recently, the microscopic study of these complex proteins has been restricted due to limitations of "force microscopes" that are available to researchers and the one-dimensional results these microscopes reveal.
A study published in the March 2013 issue of the Journal of the American Academy of Child and Adolescent Psychiatry found that 9 out of 10 young children with moderate to severe attention-deficit/hyperactivity disorder (ADHD) continue to experience serious to severe symptoms and impairment long after their original diagnoses, and in many cases, despite treatment.
› Verified 1 days ago
| Entity Name | Union Square Eye Center Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285105866 PECOS PAC ID: 9133451438 Enrollment ID: O20191105001875 |
News Archive
Elizabeth Warren and Senator Scott P. Brown kept the pressure on each other throughout a feisty, hourlong debate here Wednesday night. … Asked where he would cut the government, Mr. Brown cited President Obama's health care law, which, he said, was crushing Massachusetts businesses. He said the law would remove $700 billion from Medicare, an assertion that Mr. Romney made in last week's presidential debate.
Scientists from the University of Surrey have developed 'intelligent' nanoparticles which heat up to a temperature high enough to kill cancerous cells - but which then self-regulate and lose heat before they get hot enough to harm healthy tissue.
Dr. Reddy's Laboratories, announced today that the U.S. Food and Drug Administration has approved ZEMBRACESymTouch (sumatriptan succinate) injection, a drug-device combination product intended for the treatment of acute migraine episodes, with or without aura, in adults who are inadequately managed with existing treatment regimens.
Membrane proteins are the "gatekeepers" that allow information and molecules to pass into and out of a cell. Until recently, the microscopic study of these complex proteins has been restricted due to limitations of "force microscopes" that are available to researchers and the one-dimensional results these microscopes reveal.
A study published in the March 2013 issue of the Journal of the American Academy of Child and Adolescent Psychiatry found that 9 out of 10 young children with moderate to severe attention-deficit/hyperactivity disorder (ADHD) continue to experience serious to severe symptoms and impairment long after their original diagnoses, and in many cases, despite treatment.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Adam Seth Schneiderman, M D 200 E 33rd St, Apt 22f, New York, NY 10016-4874 Ph: (917) 445-4285 | Dr Adam Seth Schneiderman, M D 165 N Village Ave, Suite 132, Rockville Centre, NY 11570-3761 Ph: (516) 766-5851 |
News Archive
Elizabeth Warren and Senator Scott P. Brown kept the pressure on each other throughout a feisty, hourlong debate here Wednesday night. … Asked where he would cut the government, Mr. Brown cited President Obama's health care law, which, he said, was crushing Massachusetts businesses. He said the law would remove $700 billion from Medicare, an assertion that Mr. Romney made in last week's presidential debate.
Scientists from the University of Surrey have developed 'intelligent' nanoparticles which heat up to a temperature high enough to kill cancerous cells - but which then self-regulate and lose heat before they get hot enough to harm healthy tissue.
Dr. Reddy's Laboratories, announced today that the U.S. Food and Drug Administration has approved ZEMBRACESymTouch (sumatriptan succinate) injection, a drug-device combination product intended for the treatment of acute migraine episodes, with or without aura, in adults who are inadequately managed with existing treatment regimens.
Membrane proteins are the "gatekeepers" that allow information and molecules to pass into and out of a cell. Until recently, the microscopic study of these complex proteins has been restricted due to limitations of "force microscopes" that are available to researchers and the one-dimensional results these microscopes reveal.
A study published in the March 2013 issue of the Journal of the American Academy of Child and Adolescent Psychiatry found that 9 out of 10 young children with moderate to severe attention-deficit/hyperactivity disorder (ADHD) continue to experience serious to severe symptoms and impairment long after their original diagnoses, and in many cases, despite treatment.
› Verified 1 days ago
Mark Flugman, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 176 N Village Ave, Suite # 2a, Rockville Centre, NY 11570 Phone: 516-766-6400 Fax: 516-766-6457 | |
Daniel C Garibaldi, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2000 N Village Ave Ste 402, Rockville Centre, NY 11570 Phone: 516-766-2519 Fax: 516-766-3714 | |
Dr. Peter J Wong, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2000 N Village Ave, Ste 402, Rockville Centre, NY 11570 Phone: 516-766-2519 Fax: 516-766-3714 | |
Dr. David B Nelson, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2000 N Village Ave, Ste 402, Rockville Centre, NY 11570 Phone: 516-766-2519 Fax: 516-766-3714 | |
Dr. Alexander P Hatsis, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2 Lincoln Ave, Ste 401, Rockville Centre, NY 11570 Phone: 516-763-4106 Fax: 516-763-5216 | |
Dr. Eric James Sigler I, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2000 N Village Ave, Suite 402, Rockville Centre, NY 11570 Phone: 516-766-2519 Fax: 516-766-3714 | |
Dr. Nechama Shoshani, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 119 N Park Ave, Suite 208, Rockville Centre, NY 11570 Phone: 631-265-8780 |